Difference between revisions of "Team:UCopenhagen/Interdependency"

 
(50 intermediate revisions by 2 users not shown)
Line 14: Line 14:
 
                     <div class="intro-message2">
 
                     <div class="intro-message2">
 
<h3></h3>
 
<h3></h3>
                         <h1>I N T E R D E P E N D E N C Y</h1> 
+
                         <h1><a name="Top">I N T E R D E P E N D E N C Y</a></h1>
<h3></h3>
+
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 29: Line 28:
 
                     <hr class="section-heading-spacer">
 
                     <hr class="section-heading-spacer">
 
                     <div class="clearfix"></div>
 
                     <div class="clearfix"></div>
                     <h2 class="section-heading">Introduction </h2>
+
                     <h2 class="section-heading">Introduction</h2>
                     <p class="lead">Why interdependency? In order to have a stable relationship where the host-endosymbiont relationship are maintained through generations, the host and endosymbionts must depend on each other for their continued survival. <br><br>
+
                     <p class="lead">
Within the endosymbiotic relationship, we envision a resource based cross-network between host and symbiont. The exchange of vital metabolites necessary for proliferation would ensure the co-existence of the symbiotic pair while also ensuring mutual demise should either host or symbiont perish. Our goal would be that the pair would survive only if the condition of endosymbiosis is met. This is important, as our project is about laying the foundation for stable modular endosymbiosis. <br><br>
+
The first mechanism that we have decided to investigate is the interdependency between two cell types. In order to have a stable relationship in which the host-endosymbiont relationship is maintained through generations, the host and endosymbionts must depend on each other for their continued survival.  
 
+
In this subproject, we will use yeast as a substitute for the host, and E.coli as a substitute for an endosymbiont. This choice was done due to both organisms being readily available and since metabolic pathways in E.coli are well studied. Endosymbiosis between fungi and bacteria are occurring naturally in mycorrhiza (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC92331/), showing that endosymbiotic relationships between these two groups of organisms can occur.  
+
 
<br><br>
 
<br><br>
 
+
Within the endosymbiotic relationship, we envision a resource based cross-network between host and symbiont. The exchange of vital metabolites, necessary for proliferation, would ensure the coexistence of the symbiotic pair, whilst also ensuring mutual demise in case of the host’s or the symbiont’s perishment. Our goal would be that the pair would survive only if the condition of endosymbiosis is met.  
Our aim is to make yeast depend on a metabolite produced by E.coli - an auxotrophic dependence. This will be achieved by engineering an E. coli strain to produce sufficient L-tryptophan to complement the lack of tryptophan synthesis in the yeast strain when grown in a media depleted for L-tryptophan.<br><br>
+
 
+
We do not attempt to make E.coli depend on yeast at this stage, but in an endosymbiotic relationship the yeast can be grown in a media the E.coli could not survive on its own, the symbiont is thus dependent on the host for survival in these growth conditions.</p>
+
 
<br><br>
 
<br><br>
 +
This is important, as our project is about laying the foundation for stable modular endosymbiosis. We are working to establish a dependency between free living cells, as a groundwork for a later endosymbiotic relationship. Natural endosymbiotic relationships have been found between fungi and bacteria in mycorrhiza strains (<u><a href="#I5">Bianciotti, 2000</a></u>), and we will be working with two cells from these two phylogenetic kingdoms in our project; a tryptophan auxotrophic yeast AM94 and <i>E. coli</i>.
 +
</p>
 
                
 
                
 
     </div>
 
     </div>
Line 45: Line 41:
 
</div>
 
</div>
  
<div class="content-section-b">
+
<div class="content-section-b"><a name="design"></a>
 
<div class="container">
 
<div class="container">
 
             <div>
 
             <div>
                    <hr class="section-heading-spacer">
 
 
                     <div class="clearfix"></div>
 
                     <div class="clearfix"></div>
                     <h2 class="section-heading">Final Design</h2>
+
                     <h2 class="section-heading">Final Design </h2>
                    <p class="lead"><strong>Goal</strong>: In synthetic yeast media there are 76 mg tryptophane pr liter (Sigma-Aldrich, 2017), so the goal is to produce and export similar amounts from E.coli. A strain by Gu et al. (2012) had few modifications and accumulated 1.7 g tryptophane per liter: Sufficient for yeast growth.<br><br>
+
                                        <p class="lead">
In addition to this, we have included tryptophane use and production in yeast and E.coli in the modelling to check how many endosymbionts would be necessary pr host. <br><br>
+
<strong>Background</strong>: Synthetic yeast media, suitable for growth of tryptophan auxotroph yeast, contains 76mg tryptophan pr. liter (Sigma-Aldrich, 2017). An accumulation of 1.7g tryptophan pr. liter was achieved by <u><a href="#I2">Gu et al. (2012)</a></u> with a modified E.coli strain, which is sufficient for yeast growth. The production of tryptophan is regulated by negative feedback mechanisms that inhibits tryptophan synthesis in the presence of tryptophan or related amino acids.
 
+
<br><br>
<strong>Genes</strong>: Based on the papers by Gu et al., (2012) and Wang et al., (2013) three genes are overexpressed. Tryptophane production is regulated by feedback mechanisms, that we try to overcome.
+
<strong>Our goal</strong> is to produce and export enough tryptophan from E.coli to complement growth of an auxotroph yeast strain, grown in media without tryptophan. Additionally, we are interested in the number of endosymbionts necessary per host. This is included in our <a href="https://2017.igem.org/Team:UCopenhagen/Model">modelling</a>.
 +
<br><br>
 +
<strong>Circuits and biobricks</strong>: In our circuit, we are overexpressing the three genes AroG, TrpE and YddG, which will also become our biobricks. We have made our selection based on the papers by <u><a href="#I2">Gu <i>et al.</i> (2012)</a></u> and <u><a href="#I3">Wang <i>et al.</i> (2013)</a></u>.
 +
<br><br>
 +
TrpE belongs to the tryptophan operon and has been overexpressed frequently in L-tryptophan producing E. coli strains.  
 
<br><br>
 
<br><br>
 +
AroG is the first enzyme of the shikimate pathway, thereby determining the carbon flow towards tryptophan synthesis.
  
<u>trpE </u>belongs to the tryptophan operon and has been over-expressed frequently in L-tryptophan producing E. coli strains. <br>
+
</p>
<u>aroG</u>: the starting enzyme of the shikimate pathway, leading to synthesis of tryptophan. Being the first enzyme in the pathway, it determines the carbon flow towards tryptophan synthesis and thus the production.
+
  
 +
            <div class="col-lg-5 col-sm-6">
 +
                <hr class="section-heading-spacer">
 +
                <div class="clearfix"></div>
 +
                    <p class="lead"> Both AroG and TrpE (Figure 1) are regulated by the concentration of the amino acids produced. This feedback signalling reduces the tryptophan concentration that we can achieve with WT <i>E.coli</i> <i>aroG</i> and <i>trpE</i> genes, as simply overexpressing them would lead to inhibition due to increased production.
 
<br><br>
 
<br><br>
  
Both aroG and trpE (figure) are regulated by the concentration of the tryptophane they produce. This feedback signalling reduces the tryptophane concentration we can achieve in a WT E.coli. We have made use of known (Gu et al., 2012) mutant feedback resistant alleles for trpE and aroG to overcome this regulation. For trpE, mutation in a methionine to threonine at position 293 is required, and for aroG the proline at 150 is changed to leucine.<br><br>
+
We have made use of known mutant feedback resistant alleles for <i>trpE</i> and <i>aroG</i> to overcome this regulation (<u><a href="#I2">Gu et al. (2012)</a></u>). In the proteins TrpE, a mutation in a methionine to threonine at position 293 is required, and for AroG, the proline at position 150 is changed to leucine. <br><br>
  
<u>yddG</u>: an aromatic amino acid exporter. yddG is responsible for the secretion of L-tryptophan, and the over-expression of this increase the accumulation (Gu et al 2012), likely due to bypassing the feedback sensitive regulatory steps in tryptophane biosynthesis by decreasing the intracellular concentration. <br><br>
+
By making these point mutations, the feedback inhibition should be released, and overexpression would lead to elevated tryptophan production. We submitted the feedback resistant alleles as biobricks:
 +
<ul style="text-align:left; color:white;">
 +
<li><i>trpE</i>: <a href="http://parts.igem.org/Part:BBa_K2455001">BBa_K2455001</a></li>
 +
<li><i>aroG</i>: <a href="http://parts.igem.org/Part:BBa_K2455000">BBa_K2455000</a></li>
 +
</ul>
 +
</p>
 +
<p class="lead">The last gene, <i>yddG</i> is an aromatic amino acid exporter and is responsible for the secretion of both tryptophan, tyrosine and phenylalanine. <br><br>
  
 +
<u><a href="#I2">Gu <i>et al.</i> (2012)</a></u> have shown that the over-expression of YddG in <i>E.coli</i> increases the accumulation of tryptophan in the growth medium. This is likely due to the decrease in intracellular concentration, thus bypassing the feedback sensitive regulatory steps in tryptophan biosynthesis. We have designed a codon-optimised version of <i>yddG</i> that we have submittd as Biobrick <a href="http://parts.igem.org/Part:BBa_K2455004">BBa_K2455004</a>. <br><br>
 +
Constructs with each gene, or two of the genes together, will be evaluated in order to examine both the combined and isolated effects of the genes.
  
Codon-optimised, synthetically produced. </p>  
+
            </div>
 +
                <div class="col-lg-5 col-lg-offset-2 col-sm-6">
 +
<figure>
 
<br><br>
 
<br><br>
             
+
<br>
 +
                    <img class="img-responsive" src="https://static.igem.org/mediawiki/2017/d/df/TrpPathway.png" alt="" width="250" height="200">
 +
<br>
 +
<figcaption><b>Figure 1 </b>AroG and TrpE location in aromatic amino acid biosynthesis: AroG initiates the shikimate pathway, and is inhibited by Phenylalanine.
 +
TrpE is the first protein in the trp operon and inhibited by tryptophan. The red crosses indicate feedback inhibition removed by the point mutations.
 +
</figcaption>
 +
</figure>
 +
                </div>
 +
        </div>
 +
 
 
     </div>
 
     </div>
</div>
+
    <!-- /.container -->
 
</div>
 
</div>
  
<div class="content-section-a">
+
<div class="content-section-a"><a name="experiment"></a>
 
<div class="container">
 
<div class="container">
 
             <div>
 
             <div>
Line 81: Line 103:
 
                     <h2 class="section-heading">Experiments</h2>
 
                     <h2 class="section-heading">Experiments</h2>
 
                     <p class="lead">
 
                     <p class="lead">
 +
 +
<h4>Overview</h4>
 +
 
<strong>Amplification of genes:</strong>
 
<strong>Amplification of genes:</strong>
 
<ul style="text-align:left; color:white;">
 
<ul style="text-align:left; color:white;">
<li>Synthetically produce a codon-optimised version of yddG. </li>
+
<li>Synthetically produce a codon-optimised version of <i>yddG</i></li>
<li>Amplify trpE and aroG from WT E.coli MG1655</li>
+
<li>Amplify <i>trpE</i> and <i>aroG</i> with point mutations</li>
<li> Point mutations for feedback resistance in trpE and aroG: Using primers with overhangs containing point mutations, and splitting the gene in two, then combining the two parts when inserting in the expression vector. </li>
+
<li> Multi-gene constructs inserted in vector</li>
<li> Created vector with combinations of one, two and three genes in the USER casette, using primers with overhangs.</li>
+
 
</ul>
 
</ul>
 +
</p>
 +
 +
<p class="lead">
 +
<strong>Serial growth of <i>E. coli</i> and yeast</strong>
 +
<ul style="text-align:left; color:white;">
 +
<li>Identify a minimal media supporting both <i>E. coli</i> and yeast growth </li>
 +
<li>Analyse auxotrophic yeast growth in the minimal media both with and without tryptophan added </li>
 +
<li>Grow auxotrophic yeast in media only containing tryptophan produced by <i>E.coli</i> </li>
 +
</ul>
 +
</p>
 +
 +
<p class="lead">
 +
<strong>Gene expression and tryptophan production</strong>
 +
<ul style="text-align:left; color:white;">
 +
<li>Western blotting to check expression of his-tagged proteins</li>
 +
<li>HPLC-MS measurements of tryptophan production</li>
 +
</ul>
 +
</p>
 +
 +
<h4>Verifications</h4>
 +
 +
<p class="lead">
 +
 +
We have used <a href="https://static.igem.org/mediawiki/2017/c/cd/GelElectrophoresis_UCopenhagen.pdf">gel electrophoresis</a> in the majority of our experiments and sub-projects to continually monitor the progress.
 +
 
<br><br>
 
<br><br>
To make the point mutations for trpE and aroG, two sets of vectors for each gene was designed (illustration). Overhangs in the end of the primers enable USER cassette insertion, while the primer overhangs in the center contain a point mutation. When the two parts are being amplified individually, the transformation into vector in expression host will be done with USER ligation.
+
 
 +
All <a href="https://static.igem.org/mediawiki/2017/9/94/Protocol8_UCopenhagen.pdf">transformations</a> in interdependency and protein import were done with USER <a href="https://static.igem.org/mediawiki/2017/2/25/Protocol7_UCopenhagen.pdf">cloning</a>and the cells were grown ON on <a href="https://static.igem.org/mediawiki/2017/6/62/Protocol14_UCopenhagen.pdf">LB</a> agar with the appropriate selection (Ampicillin or Chloramphenicol depending on the resistance marker). <a href="https://static.igem.org/mediawiki/2017/b/b0/Protocol16_UCopenhagen.pdf">Colony PCR</a>s were performed to pick colonies with the correct inserts for inoculation in liquid culture.  
 +
 
 
<br><br>
 
<br><br>
<strong>Vector design</strong>
+
 
Protein import. USER casette and His tag. <br>
+
Subsequently, plasmids were <a href="https://static.igem.org/mediawiki/2017/c/c6/Protocol3_UCopenhagen.pdf">cured</a> from the cultures and <a href="https://static.igem.org/mediawiki/2017/2/2e/Protocol1_UCopenhagen.pdf">PCR</a> amplification and/or restriction <a href="https://static.igem.org/mediawiki/2017/a/ab/Protocol13_UCopenhagen.pdf">digestion</a> were used to check for correct insertion. Cells with appropriately sized inserts were sent to <a href="https://static.igem.org/mediawiki/2017/9/9f/Protocol17_UCopenhagen.pdf">sequencing</a> for sequence validation.
Vector design was performed in the protein import subproject, and the same vector was used for all cloning in the interdependency project.
+
              </p>
 +
 
 +
<h4>Biobrick creation</h4>
 +
 
 +
<p class="lead">
 +
 
 +
We amplified our biobricks with primers carrying the biobrick prefixes and suffixes as overhangs, and purified them with gel extraction. Subsequently, we used the standard iGEM protocol for its insertion into the pSB1C3 submission vector. <br><br>
 +
All biobricks were sequenced in the expression vector, and <i>aroG</i>, <i>trpE</i>, CPP and CPP-YFP were also sequenced following their insertion into the submission vector. <br> </p>
 +
 
 +
<h4>Vector design</h4>
 +
 
 +
<p class="lead">
 +
 
 +
A modified version of the <a href="https://www.addgene.org/vector-database/2623/">pET102 vector</a> was used for expression of all genes in this sub-project. See <a href="https://2017.igem.org/Team:UCopenhagen/Protein-Import">protein import</a> for details on design and creation of the vector.<br></p>
 +
 
 +
<h4>Codon optimization and synthetic <i>yddG</i></h4>
 +
 
 +
<p class="lead">
 +
 
 +
Following problems with amplifying <i>yddG</i> from the genomic DNA, we decided to order a synthetically made version, and codon optimized it in the process.<br></p>
 +
 
 +
<h4>Point mutations for feedback resistance in <i>trpE</i> and <i>aroG</i></h4>
 +
 
 +
<p class="lead">
 +
 
 +
We amplified the <i>aroG</i> and <i>trpE</i> genes using genomic DNA from <i>E.coli</i> strain MG1655. The amplification was done using two sets of primers per gene, with overhangs allowing for insertion of a point mutation in each gene and for cloning with USER assembly. <br><br>
 +
 
 +
The mutations were designed in accordance with previous work by <u><a href="#I2">Gu <i>et al.</i> (2012)</a></u>. In TrpE, position 293 is changed from methionine to threonine, and for AroG position 150 is changed from proline to leucine.
 +
<figure>
 
<br><br>
 
<br><br>
<strong>Expression and production</strong>
+
                    <img class="img-responsive" src="https://static.igem.org/mediawiki/2017/5/5d/TrpE_pointmutation.png" alt="" width="250" height="200">
 +
<br>
 +
<figcaption><b>Figure 2 </b>Point mutation in <i>trpE</i>, and insertion in vector with USER assembly. To perform the point mutation, we designed two sets of primers for each gene. The outer primers are the same as used for amplification from the genomic DNA. The central primers have overhangs containing the point mutations.
 +
This way, the genes are split in two, and the two parts are combined when inserting in the USER cassette in the expression vector - and now containing a point mutation in the middle.
 +
</figcaption>
 +
</figure>
 +
</p>
 +
 
 +
<h4>Multi-gene constructs</h4>
 +
 
 +
<p class="lead">
 +
To evaluate the effect of the proteins, we made multi-gene constructs.
 +
The constructs were made by designing primers with overhangs encoding Ribosome Binding Sites (RBS). RBS makes sure all genes will be transcribed, and the overhangs enable combination of the genes into multi-gene constructs (fig 3) and USER assembly.<br><br>
 +
We created biobricks of one or two genes in combination. We attempted to make all the following constructs into biobricks, but did not succeed with the 3 gene construct.
 
<ul style="text-align:left; color:white;">
 
<ul style="text-align:left; color:white;">
<li>Expression checked with Western blotting: all genes HIS tagged. </li>
+
<li>YddG-his</li>
<li>Tryptophane production by E.coli with one, two or three genes, and nuder different levels of inducing agents evaluated on HPLC</li>
+
<li>TrpE-his</li>
 +
<li>AroG-his</li>
 +
<li>YddG-TrpE-his: <a href="http://parts.igem.org/Part:BBa_K2455007">BBa_K2455007</a></li>
 +
<li>YddG-AroG-his: <a href="http://parts.igem.org/Part:BBa_K2455008">BBa_K2455008</a></li>
 +
<li>YddG-TrpE-AroG-his</li>
 
</ul>
 
</ul>
 +
</p>
 +
 +
<p class="lead">
 +
<figure>
 
<br><br>
 
<br><br>
<strong>Co-growth of E.coli and yeast</strong>
+
                    <img class="img-responsive" src="https://static.igem.org/mediawiki/2017/f/ff/Construct_insertions2.png" alt="" width="250" height="200">
 +
<br>
 +
<figcaption><b>Figure 3 </b>Multi-gene constructs were created with a series of primers with overhangs coding for Ribosome Binding Sites (RBS) between the genes. The outer primers coded for USER overhangs for USER ligation. 
 +
</figcaption>
 +
</figure>
 +
</p>
 +
 
 +
<h4>Serial growth experiment of <i>E.coli</i> and yeast</h4>
 +
<p class="lead">
 +
<i>E. coli</i> strains MG1655 and BL21 were grown in several media, until we settled on the minimal yeast media YNB with the pH adjusted to 7 (<u><a href="#I1">van Summeren-Wesenhagen and Marienhagen, 2014</a></u>). <br><br>
 +
 
 +
To ensure that <i>E.coli</i> do not produce substances hindering yeast growth, we performed an initial serial growth experiment, shown in figure 4. The serial growth experiment was performed with ON growth of <i>E.coli</i> in YNB pH 7, clearing the media of E.coli by spinning and filtration through 0.2 µm filters, and inoculating with yeast (AM94).
 +
<figure>
 +
<br><br>
 +
                    <img class="img-responsive" src="https://static.igem.org/mediawiki/2017/4/42/Serialgrowth1.png" alt="" width="250" height="200">
 +
<br>
 +
<figcaption><b>Figure 4 </b>Serial growth experiment. 1) E.coli from liquid culture in LB media is inoculated in YNB media. 2) After sufficient growth of E.coli in YNB, the media is cleared of E.coli by spinning and filtration. 3) E.coli free media is then inoculated with tryptophan auxotroph yeast.
 +
</figcaption>
 +
</figure>
 +
</p>
 +
 
 +
<h4>Serial growth experiment with transformed <i>E.coli</i></h4>
 +
<p class="lead">
 +
To evaluate, if the complementation of the yeast amino acid auxotrophy by <i>E.coli</i> tryptophan production is successful, we made serial growth experiments with transformed <i>E. coli</i>. <br><br>
 +
We first growed the E.coli, transformed with the single, double and triple construct vectors described above in <a href="https://static.igem.org/mediawiki/2017/f/f6/Protocol18_UCopenhagen.pdf">YNB media</a> without a tryptophane source. Subsequently, we cleared the media and inoculated it with auxotroph yeast, then evaluated the growth using OD<sub>600</sub> measurements. <br><br>
 +
 
 +
We also checked the growth of auxotrophic yeast in the media with and without added tryptophan, to ensure that any growth after <i>E.coli</i> growth was due to tryptophan being produced by <i>E.coli</i> and not due to the yeast overcoming the auxotrophy.
 +
All serial growth experiments used variations of the same <a href="https://static.igem.org/mediawiki/2017/0/0e/Protocol19_UCopenhagen.pdf">protocol</a>.
 +
</p>
 +
 
 +
 
 +
            <div class="col-lg-5 col-sm-6">
 +
                <hr class="section-heading-spacer">
 +
                <div class="clearfix"></div>
 +
 
 +
<h4>HPLC measurements of tryptophan production</h4>
 +
<p class="lead">
 +
In addition to the qualitative assessment of tryptophan production by yeast growth, we made a quantitative evaluation of tryptophan production by our transformed <i>E.coli</i>. <br><br>
 +
We used <a href="https://static.igem.org/mediawiki/2017/b/b8/Protocol20_UCopenhagen.pdf">HPLC-MS </a> with a program for amino acid detection to measure the concentration of tryptophan in the media after 10-40 hours growth. Internal and external standards were used. Simultaneously, we measured concentrations of tyrosine and phenylalanine, which should be increased when AroG is expressed. <br><br>
 +
 
 +
We measure production from the following transformations of E. coli.
 
<ul style="text-align:left; color:white;">
 
<ul style="text-align:left; color:white;">
<li>Find yeast minimal media where E.coli can grow</li>
+
<li>empty vector</li>
<li>Grow yeast in same media after E.coli has grown, in order to establish possibility for relationship.</li>
+
<li>YddG-his</li>
<li>Grow tryptophane producing E.coli for different time periods, then remove them and grow auxotrophic yeast in the media containing the produced tryptophane. </li>
+
<li>TrpE-his </li>
 +
<li>AroG-his</li>
 +
<li>YddG-TrpE-his</li>
 +
<li>YddG-AroG-his</li>
 +
<li>YddG-TrpE-AroG-his</li>
 +
<li>YddG-TrpE-AroG</li>
 
</ul>
 
</ul>
 +
</p>
 +
<p class="lead">Growth of these transformants are simultaneously monitored with OD<sub>600</sub> measurements. </p>
 +
</div>
 +
 +
  <div class="col-lg-5 col-lg-offset-2 col-sm-6">
 
<br><br>
 
<br><br>
<strong>Growth of E.coli and yeast in same minimal yeast medium</strong>
 
E. coli strains MG1655 and BL21 were grown in several media in order to find a minimal yeast media where E.coli could survive. With inspiration from (van Summeren-Wesenhagen and Marienhagen, 2014), we decided to grow E.coli in the minimal yeast media YNB with the pH adjusted to 7 instead of 4 as original.
 
<br>
 
After ON growth of E.coli in YNB pH 7, the media was cleared of E.coli by spinning and filtration, after which it was inoculated with yeast (AM94), to ensure that the E.coli does not produce substances hindering yeast growth (protocol).<br>
 
This experiment is a prerequisite for our next experiment.
 
 
<br><br>
 
<br><br>
<strong>Growth of tryptophan auxotrophic yeast in minimal medium subsequent to tryptophan producing E.coli</strong>
+
<figure>
This experiment utilizes the same protocol as the previous (protocol), but now in YNB pH7 media without a tryptophan source, with tryptophan overproducing E.coli and with a tryptophan auxotrophic yeast strain.<br><br>
+
                    <img class="img-responsive3" src="https://static.igem.org/mediawiki/2017/9/97/HPLC-MS-foto.jpg" alt="" width="250" height="200">
This experiment is performed with single, double and triple transformations: That is, E.coli with trpE(fbr), aroG(fbr) and yddG alone or in combinations. <br><br>
+
<br>
The growth of yeast is measured using OD600 measurements to evaluate the successful complementation of the yeast amino acid auxotrophy by E.coli tryptophan production. <br><br>
+
<figcaption><b>Figure 5 </b>Photo of the HPLC-MS set-up.
              </p>
+
</figcaption>
    </div>
+
</figure>
 
</div>
 
</div>
 +
</div>
 +
    </div>
 
</div>
 
</div>
 
          
 
          
Line 128: Line 275:
 
                     <hr class="section-heading-spacer">
 
                     <hr class="section-heading-spacer">
 
                     <div class="clearfix"></div>
 
                     <div class="clearfix"></div>
                     <h2 class="section-heading">Design process</h2>
+
                     <h2 class="section-heading">Design process/future</h2>
<p class="lead"><strong>Natural endosymbiosis (our model)</strong> Shortly: what is endosymbiosis?
+
<p class="lead">
 +
<strong>Summary</strong>: We cloned <i>E.coli</i> strains to express proteins in the tryptophan synthesis pathway, and have measured the production of these cells. We have ensured that auxotroph yeast can grow after <i>E.coli</i> in the same media, and have attempted to grow it on the tryptophan produced by <i>E. coli</i> as the single tryptophan source.
 
<br><br>
 
<br><br>
<strong> Synthetic endosymbiosis </strong> will have innumerable applications if developed to be the orthogonal system we envision. We have chosen to take a bottom-up approach to it, through the investigation of the following three essential mechanisms.
+
In our design process, we have considered a wide range of possible gene combinations and interdependency mechanisms. We settled on a simple amino acid interdependency which is easy to test with an amino acid auxotroph yeast.  
Add something about how our idea started?
+
<br><br>
+
<strong> Interdependence </strong> between host and endosymbiont is necessary in order for the endosymbiotic relationship to be stable and maintained throughout evolution or, more relevant for synthetic biology, through generations. The relationship should be beneficial and crucial for the host and the endosymbiont alike. Interdependency would thus decrease possible safety concerns: without the dependency relationship, the endosymbiotic relationship will not spread and be maintained in a wild population.
+
<br><br>
+
<strong>Number control</strong> addresses our concern that the endosymbiont will thrive too well in the host, and replicate uncontrollably - thus overwhelming the host system - or be lost in host replications. Thus we strive for a way to maintain a stable number of endosymbionts in the system. A control system that repress endosymbiont reproduction in high concentration/numbers, and allow replication when the concentration is decreased, would address this concern.
+
<br><br>
+
<strong>Protein import</strong> is a common trait observed in naturally occurring endosymbiotic relationships, such as mitochondria and chloroplasts. In these cases a down regulation of protein expression in the symbiont is observed, and the protein expression is instead moved to the cell. Proteins expressed in mitochondria and chloroplasts are transcribed in the nucleus, translated in the cytoplasm and subsequently transported across the cell membranes into the endosymbionts. This mechanism would tighten the relationship between host and symbiont, and would allow endosymbiotic manipulation of precursors produced in the host. </p>
+
 
<br><br>
 
<br><br>
 +
In a final version of an endosymbiotic relationship, amino acid dependency might not be the optimal dependency as it would not allow the system to be grown on a media with all amino acids that might be required for co-cultures for added modularity. Instead of tryptophan, a different, but vital metabolite could be supplied by the symbiont. <br><br>
 +
To perform our tryptophan overproduction, we chose genes that, when over-expressed would have the greatest impact, based on the article by <u><a href="#I2">Gu <i>et al.</i> (2012)</a></u>. Initially, we considered simply overexpressing the tryptophan operon, but quickly realised this would be highly downregulated due to negative feedback regulation.<br><br>
 +
To release the feedback regulation, we decided on an amino acid translocator to reduce the intracellular tryptophan concentration. Several deletions of e.g. endogenous trpR has also been considered, but this would make our project overly complicated due to the difficulty of making such deletions in <i>E.coli</i>.
 +
</p>
 
                   </div>
 
                   </div>
 
                 </div>
 
                 </div>
 
                 </div>
 
                 </div>
 +
 +
 +
<div class="content-section-a"><a name="proces"></a>
 +
<div class="container">
 +
            <div>
 +
                    <hr class="section-heading-spacer">
 +
                    <div class="clearfix"></div>
 +
                    <h2 class="section-heading">References</h2>
 +
                    <p class="lead">
 +
<a name="I1">Summeren-Wesenhagen, P. V., & Marienhagen, J. (2014). Metabolic Engineering of Escherichia coli for the Synthesis of the Plant Polyphenol Pinosylvin. <i>Applied and Environmental Microbiology, 81</i>(3), 840-849. doi:10.1128/aem.02966-14</a>
 +
<br><br>
 +
<a name="I2">Gu, P., Yang, F., Kang, J., Wang, Q., & Qi, Q. (2012). One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of L-tryptophan in Escherichia coli. <i>Microbial Cell Factories, 11</i>(1), 30. doi:10.1186/1475-2859-11-30</a>
 +
<br><br>
 +
<a name="I3">Wang, J., Cheng, L., Wang, J., Liu, Q., Shen, T., & Chen, N. (2013). Genetic engineering of Escherichia coli to enhance production of l-tryptophan. <i>Applied Microbiology and Biotechnology, 97</i>(17), 7587-7596. doi:10.1007/s00253-013-5026-3</a>
 +
<br><br>
 +
<a name="I4">Sigma-Aldrich. (2017). Yeast Synthetic Drop-out Medium Supplements Y1501. (n.d.). Retrieved October 31, 2017, from http://www.sigmaaldrich.com/catalog/product/sigma/y1501?lang=en&region=DK</a>
 +
<br><br>
 +
<a name="I5">Bianciotto, V., Lumini, E., Lanfranco, L., Minerdi, D., Bonfante, P., & Perotto, S. (2000). Detection and Identification of Bacterial Endosymbionts in Arbuscular Mycorrhizal Fungi Belonging to the Family Gigasporaceae. <i>Applied and Environmental Microbiology, 66</i>(10), 4503-4509. doi:10.1128/aem.66.10.4503-4509.2000</a>
 +
<br><br>
 +
<strong>Reference for USER cloning</strong>:
 +
<br>
 +
<a name="I6">Nour-Eldin, H. H., Hansen, B. G., Nørholm, M. H., Jensen, J. K., & Halkier, B. A. (2006). Advancing uracil-excision based cloning towards an ideal technique for cloning PCR fragments. <i>Nucleic Acids Research, 34</i>(18). doi:10.1093/nar/gkl635</a>
 +
<br><br>
 +
<strong>Reference for USER fusion</strong>:
 +
<br>
 +
<a name="I7">Geu-Flores, F., Nour-Eldin, H. H., Nielsen, M. T., & Halkier, B. A. (2007). USER fusion: a rapid and efficient method for simultaneous fusion and cloning of multiple PCR products. <i>Nucleic Acids Research, 35</i>(7). doi:10.1093/nar/gkm106</a>
 +
</p>
 +
             
 +
</div>
 +
</div>
 +
</div>
  
 
<a  name="socialmedia"></a>
 
<a  name="socialmedia"></a>

Latest revision as of 00:53, 2 November 2017


Introduction

The first mechanism that we have decided to investigate is the interdependency between two cell types. In order to have a stable relationship in which the host-endosymbiont relationship is maintained through generations, the host and endosymbionts must depend on each other for their continued survival.

Within the endosymbiotic relationship, we envision a resource based cross-network between host and symbiont. The exchange of vital metabolites, necessary for proliferation, would ensure the coexistence of the symbiotic pair, whilst also ensuring mutual demise in case of the host’s or the symbiont’s perishment. Our goal would be that the pair would survive only if the condition of endosymbiosis is met.

This is important, as our project is about laying the foundation for stable modular endosymbiosis. We are working to establish a dependency between free living cells, as a groundwork for a later endosymbiotic relationship. Natural endosymbiotic relationships have been found between fungi and bacteria in mycorrhiza strains (Bianciotti, 2000), and we will be working with two cells from these two phylogenetic kingdoms in our project; a tryptophan auxotrophic yeast AM94 and E. coli.

Final Design

Background: Synthetic yeast media, suitable for growth of tryptophan auxotroph yeast, contains 76mg tryptophan pr. liter (Sigma-Aldrich, 2017). An accumulation of 1.7g tryptophan pr. liter was achieved by Gu et al. (2012) with a modified E.coli strain, which is sufficient for yeast growth. The production of tryptophan is regulated by negative feedback mechanisms that inhibits tryptophan synthesis in the presence of tryptophan or related amino acids.

Our goal is to produce and export enough tryptophan from E.coli to complement growth of an auxotroph yeast strain, grown in media without tryptophan. Additionally, we are interested in the number of endosymbionts necessary per host. This is included in our modelling.

Circuits and biobricks: In our circuit, we are overexpressing the three genes AroG, TrpE and YddG, which will also become our biobricks. We have made our selection based on the papers by Gu et al. (2012) and Wang et al. (2013).

TrpE belongs to the tryptophan operon and has been overexpressed frequently in L-tryptophan producing E. coli strains.

AroG is the first enzyme of the shikimate pathway, thereby determining the carbon flow towards tryptophan synthesis.


Both AroG and TrpE (Figure 1) are regulated by the concentration of the amino acids produced. This feedback signalling reduces the tryptophan concentration that we can achieve with WT E.coli aroG and trpE genes, as simply overexpressing them would lead to inhibition due to increased production.

We have made use of known mutant feedback resistant alleles for trpE and aroG to overcome this regulation (Gu et al. (2012)). In the proteins TrpE, a mutation in a methionine to threonine at position 293 is required, and for AroG, the proline at position 150 is changed to leucine.

By making these point mutations, the feedback inhibition should be released, and overexpression would lead to elevated tryptophan production. We submitted the feedback resistant alleles as biobricks:

The last gene, yddG is an aromatic amino acid exporter and is responsible for the secretion of both tryptophan, tyrosine and phenylalanine.

Gu et al. (2012) have shown that the over-expression of YddG in E.coli increases the accumulation of tryptophan in the growth medium. This is likely due to the decrease in intracellular concentration, thus bypassing the feedback sensitive regulatory steps in tryptophan biosynthesis. We have designed a codon-optimised version of yddG that we have submittd as Biobrick BBa_K2455004.

Constructs with each gene, or two of the genes together, will be evaluated in order to examine both the combined and isolated effects of the genes.





Figure 1 AroG and TrpE location in aromatic amino acid biosynthesis: AroG initiates the shikimate pathway, and is inhibited by Phenylalanine. TrpE is the first protein in the trp operon and inhibited by tryptophan. The red crosses indicate feedback inhibition removed by the point mutations.

Experiments

Overview

Amplification of genes:
  • Synthetically produce a codon-optimised version of yddG
  • Amplify trpE and aroG with point mutations
  • Multi-gene constructs inserted in vector

Serial growth of E. coli and yeast

  • Identify a minimal media supporting both E. coli and yeast growth
  • Analyse auxotrophic yeast growth in the minimal media both with and without tryptophan added
  • Grow auxotrophic yeast in media only containing tryptophan produced by E.coli

Gene expression and tryptophan production

  • Western blotting to check expression of his-tagged proteins
  • HPLC-MS measurements of tryptophan production

Verifications

We have used gel electrophoresis in the majority of our experiments and sub-projects to continually monitor the progress.

All transformations in interdependency and protein import were done with USER cloningand the cells were grown ON on LB agar with the appropriate selection (Ampicillin or Chloramphenicol depending on the resistance marker). Colony PCRs were performed to pick colonies with the correct inserts for inoculation in liquid culture.

Subsequently, plasmids were cured from the cultures and PCR amplification and/or restriction digestion were used to check for correct insertion. Cells with appropriately sized inserts were sent to sequencing for sequence validation.

Biobrick creation

We amplified our biobricks with primers carrying the biobrick prefixes and suffixes as overhangs, and purified them with gel extraction. Subsequently, we used the standard iGEM protocol for its insertion into the pSB1C3 submission vector.

All biobricks were sequenced in the expression vector, and aroG, trpE, CPP and CPP-YFP were also sequenced following their insertion into the submission vector.

Vector design

A modified version of the pET102 vector was used for expression of all genes in this sub-project. See protein import for details on design and creation of the vector.

Codon optimization and synthetic yddG

Following problems with amplifying yddG from the genomic DNA, we decided to order a synthetically made version, and codon optimized it in the process.

Point mutations for feedback resistance in trpE and aroG

We amplified the aroG and trpE genes using genomic DNA from E.coli strain MG1655. The amplification was done using two sets of primers per gene, with overhangs allowing for insertion of a point mutation in each gene and for cloning with USER assembly.

The mutations were designed in accordance with previous work by Gu et al. (2012). In TrpE, position 293 is changed from methionine to threonine, and for AroG position 150 is changed from proline to leucine.




Figure 2 Point mutation in trpE, and insertion in vector with USER assembly. To perform the point mutation, we designed two sets of primers for each gene. The outer primers are the same as used for amplification from the genomic DNA. The central primers have overhangs containing the point mutations. This way, the genes are split in two, and the two parts are combined when inserting in the USER cassette in the expression vector - and now containing a point mutation in the middle.

Multi-gene constructs

To evaluate the effect of the proteins, we made multi-gene constructs. The constructs were made by designing primers with overhangs encoding Ribosome Binding Sites (RBS). RBS makes sure all genes will be transcribed, and the overhangs enable combination of the genes into multi-gene constructs (fig 3) and USER assembly.

We created biobricks of one or two genes in combination. We attempted to make all the following constructs into biobricks, but did not succeed with the 3 gene construct.




Figure 3 Multi-gene constructs were created with a series of primers with overhangs coding for Ribosome Binding Sites (RBS) between the genes. The outer primers coded for USER overhangs for USER ligation.

Serial growth experiment of E.coli and yeast

E. coli strains MG1655 and BL21 were grown in several media, until we settled on the minimal yeast media YNB with the pH adjusted to 7 (van Summeren-Wesenhagen and Marienhagen, 2014).

To ensure that E.coli do not produce substances hindering yeast growth, we performed an initial serial growth experiment, shown in figure 4. The serial growth experiment was performed with ON growth of E.coli in YNB pH 7, clearing the media of E.coli by spinning and filtration through 0.2 µm filters, and inoculating with yeast (AM94).




Figure 4 Serial growth experiment. 1) E.coli from liquid culture in LB media is inoculated in YNB media. 2) After sufficient growth of E.coli in YNB, the media is cleared of E.coli by spinning and filtration. 3) E.coli free media is then inoculated with tryptophan auxotroph yeast.

Serial growth experiment with transformed E.coli

To evaluate, if the complementation of the yeast amino acid auxotrophy by E.coli tryptophan production is successful, we made serial growth experiments with transformed E. coli.

We first growed the E.coli, transformed with the single, double and triple construct vectors described above in YNB media without a tryptophane source. Subsequently, we cleared the media and inoculated it with auxotroph yeast, then evaluated the growth using OD600 measurements.

We also checked the growth of auxotrophic yeast in the media with and without added tryptophan, to ensure that any growth after E.coli growth was due to tryptophan being produced by E.coli and not due to the yeast overcoming the auxotrophy. All serial growth experiments used variations of the same protocol.


HPLC measurements of tryptophan production

In addition to the qualitative assessment of tryptophan production by yeast growth, we made a quantitative evaluation of tryptophan production by our transformed E.coli.

We used HPLC-MS with a program for amino acid detection to measure the concentration of tryptophan in the media after 10-40 hours growth. Internal and external standards were used. Simultaneously, we measured concentrations of tyrosine and phenylalanine, which should be increased when AroG is expressed.

We measure production from the following transformations of E. coli.

  • empty vector
  • YddG-his
  • TrpE-his
  • AroG-his
  • YddG-TrpE-his
  • YddG-AroG-his
  • YddG-TrpE-AroG-his
  • YddG-TrpE-AroG

Growth of these transformants are simultaneously monitored with OD600 measurements.






Figure 5 Photo of the HPLC-MS set-up.

Design process/future

Summary: We cloned E.coli strains to express proteins in the tryptophan synthesis pathway, and have measured the production of these cells. We have ensured that auxotroph yeast can grow after E.coli in the same media, and have attempted to grow it on the tryptophan produced by E. coli as the single tryptophan source.

In our design process, we have considered a wide range of possible gene combinations and interdependency mechanisms. We settled on a simple amino acid interdependency which is easy to test with an amino acid auxotroph yeast.

In a final version of an endosymbiotic relationship, amino acid dependency might not be the optimal dependency as it would not allow the system to be grown on a media with all amino acids that might be required for co-cultures for added modularity. Instead of tryptophan, a different, but vital metabolite could be supplied by the symbiont.

To perform our tryptophan overproduction, we chose genes that, when over-expressed would have the greatest impact, based on the article by Gu et al. (2012). Initially, we considered simply overexpressing the tryptophan operon, but quickly realised this would be highly downregulated due to negative feedback regulation.

To release the feedback regulation, we decided on an amino acid translocator to reduce the intracellular tryptophan concentration. Several deletions of e.g. endogenous trpR has also been considered, but this would make our project overly complicated due to the difficulty of making such deletions in E.coli.


References

Summeren-Wesenhagen, P. V., & Marienhagen, J. (2014). Metabolic Engineering of Escherichia coli for the Synthesis of the Plant Polyphenol Pinosylvin. Applied and Environmental Microbiology, 81(3), 840-849. doi:10.1128/aem.02966-14

Gu, P., Yang, F., Kang, J., Wang, Q., & Qi, Q. (2012). One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of L-tryptophan in Escherichia coli. Microbial Cell Factories, 11(1), 30. doi:10.1186/1475-2859-11-30

Wang, J., Cheng, L., Wang, J., Liu, Q., Shen, T., & Chen, N. (2013). Genetic engineering of Escherichia coli to enhance production of l-tryptophan. Applied Microbiology and Biotechnology, 97(17), 7587-7596. doi:10.1007/s00253-013-5026-3

Sigma-Aldrich. (2017). Yeast Synthetic Drop-out Medium Supplements Y1501. (n.d.). Retrieved October 31, 2017, from http://www.sigmaaldrich.com/catalog/product/sigma/y1501?lang=en&region=DK

Bianciotto, V., Lumini, E., Lanfranco, L., Minerdi, D., Bonfante, P., & Perotto, S. (2000). Detection and Identification of Bacterial Endosymbionts in Arbuscular Mycorrhizal Fungi Belonging to the Family Gigasporaceae. Applied and Environmental Microbiology, 66(10), 4503-4509. doi:10.1128/aem.66.10.4503-4509.2000

Reference for USER cloning:
Nour-Eldin, H. H., Hansen, B. G., Nørholm, M. H., Jensen, J. K., & Halkier, B. A. (2006). Advancing uracil-excision based cloning towards an ideal technique for cloning PCR fragments. Nucleic Acids Research, 34(18). doi:10.1093/nar/gkl635

Reference for USER fusion:
Geu-Flores, F., Nour-Eldin, H. H., Nielsen, M. T., & Halkier, B. A. (2007). USER fusion: a rapid and efficient method for simultaneous fusion and cloning of multiple PCR products. Nucleic Acids Research, 35(7). doi:10.1093/nar/gkm106

Find Incell here: